Evidence map›Paper›PMID 32860887›Full record

ArticleNeuroscience letters2020

The role of KCC2 in hyperexcitability of the neonatal brain.

Yogendra H Raol, Srdjan M Joksimovic, Dayalan Sampath, Brock A Matter, Philip M Lam, Uday B Kompella, Slobodan M Todorovic, Marco I González

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Neuronal KActa pharmacologica Sinica · 2024
    Review
  7. Article
  8. The role ofJournal of pharmaceutical analysis · 2023
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yogendra H RaolDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Yogendra.Raol@cuanschutz.edu.
Srdjan M JoksimovicDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Dayalan SampathDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Brock A MatterDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Philip M LamDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Uday B KompellaDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Slobodan M TodorovicDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Marco I GonzálezDepartment of Pediatrics, Division of Neurology, School of Medicine, Translational Epilepsy Research Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Marco.Gonzalez@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · US

Funding

ZEBRAFISH TRANSGENIC CORE - ROCKY MOUNTAIN NEUROLOGICAL DISORDERS CORE CENTERP30NS048154 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2004 to 2020
$10.1M
In vivo imaging of thalamocortical excitability during anesthesiaR01GM102525 · NIGMS · UNIVERSITY OF VIRGINIA · PI TODOROVIC, SLOBODAN M. · 2014 to 2020
$2.0M
The Role of Proteolysis in EpileptogenesisR01NS089698 · NINDS · UNIVERSITY OF COLORADO DENVER · PI GONZALEZ, MARCO I. · 2015 to 2019
$1.7M
Neuronal Transdifferention in vivo: Mechanism and PotentialR01NS086839 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2014 to 2018
$1.7M
Efficacy of flupirtine for treatment of neonatal hypoxic-ischemic encephalopathyR01HD065534 · NICHD · UNIVERSITY OF COLORADO DENVER · PI RAOL, YOGENDRA H · 2011 to 2014
$1.1M
NICHD NIH HHS R01 HD065534NIGMS NIH HHS R01 GM102525NINDS NIH HHS P30 NS048154NINDS NIH HHS R01 NS086839NINDS NIH HHS R01 NS089698
6 · The paper itself

Abstract

backgroundThe hyperpolarizing activity of γ-aminobutyric acid A (GABA

methodsEx vivo electrophysiology experiments were performed on hippocampal slices prepared from 7 to 9 days-old (P7-P9) male rats. Excitability of CA1 pyramidal neurons bathed in zero-Mg

resultsEx vivo blockade of KCC2 by VU0463271 significantly increased the frequency of zero-Mg

conclusionThe results suggest that KCC2 plays a critical functional role in maintaining the balance of excitation-inhibition in the neonatal brain, and thus it can be used as a therapeutic target to ameliorate injury associated with hyperexcitability in newborns.

Indexed as

Action PotentialsAnimalsElectroencephalographyHippocampusK Cl- CotransportersMalePyramidal CellsRatsRats, Sprague-DawleySeizuresSymportersK Cl- CotransportersSymportersChloride transporterHyperexcitabilityHypoxia-ischemiaKCC2NewbornSeizures

Identifiers

PMID32860887
PMCPMC7584761
OpenAlexW3080720944

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.